Saed News: A wealthy American billionaire recently underwent a procedure that scientists compare to a "human oil change," completely replacing his blood plasma with albumin.
According to the Society section of Saed News, Bryan Johnson, a 47-year-old American billionaire, recently underwent a procedure called Total Plasma Exchange (TPE) and claimed it is a promising treatment for various diseases.
As reported by India Today, Johnson wrote in a recent post on the platform X that this method, which involves removing and replacing the patient’s plasma, has attracted attention for its potential to manage and treat a wide range of illnesses.
Plasma is the liquid portion of blood that carries cells, nutrients, hormones, and waste throughout the body. Johnson explained: “Total Plasma Exchange removes all the plasma from my body and replaces it with albumin. The therapeutic goal is to eliminate toxins from my system.”
Albumin is a protein produced by the liver that helps maintain fluid balance, transport nutrients, and support tissue function. It prevents fluid from leaking out of blood vessels and plays a key role in various medical treatments. Low levels of albumin can signal liver or kidney problems, or malnutrition. In medicine, albumin is used to replenish lost blood volume and support procedures such as plasma exchange, aiding in tissue growth and repair.
Previously, Johnson replaced one liter of his own plasma with his son’s plasma and donated his own plasma to his father. After receiving the plasma, Johnson claimed his father’s biological aging slowed by 25 years and remained that way for six months. The billionaire revealed that the full plasma exchange procedure took two hours.
Total Plasma Exchange is a medical procedure in which a large volume of a patient’s plasma is removed and replaced with donor plasma or a plasma substitute. This process helps eliminate harmful substances such as autoantibodies, immune complexes, and toxins from the bloodstream. Experts liken the procedure to a “human oil change.”
Studies have shown that total plasma exchange can help treat autoimmune diseases, neurological disorders, and blood-related conditions. For example, research published by the American Society of Hematology highlighted the effectiveness of this procedure in treating diseases such as myasthenia gravis, Guillain-Barré syndrome, and thrombotic thrombocytopenic purpura.
Plasma exchange has also been used in intensive care units to manage critically ill patients, showcasing its adaptability and life-saving potential.
